About Us
Zhuhai Trinomab Biopharmaceutical Co., Ltd. (hereafter referred to as "Trinomab"), is a biopharmaceutical company dedicated to developing and commercializing the innovative therapeutics on a global scale. Founded in 2015 and guided by the philosophy "Creating Clinical Value for Patients", the company is committed to advancing its proprietary HitmAb® technological platform. This platform facilitates the discovery and manufacturing of fully human monoclonal antibodies (mAbs), which serve as alternatives to blood-derived immunoglobulin products.
HitmAb® 4th Generation Antibody Technology "HitmAb® High-Throughput Fully Human Monoclonal Antibody R&D Integrated Technology Platform "
News Center
Join Us

Trinomab therapeutics for you regardless poor or rich , in sickness or health.


Trinomab is making the transition from an early R&D biotech company to a biopharmaceutical company and eventually a global pharmaceutical

Trinomab is open to all talents having a passion for biopharmaceutical industry


To learn more jobs offered by Trinomab, you can click the link to the company's home page on the following recruitment platforms:

Trinomab at BOSS   Trinomab at www. 51job.com   Trinomab at www. liepin.com